214 related articles for article (PubMed ID: 33152763)
1. DNA hypermethylation of the ZNF132 gene participates in the clinicopathological aggressiveness of 'pan-negative'-type lung adenocarcinomas.
Hamada K; Tian Y; Fujimoto M; Takahashi Y; Kohno T; Tsuta K; Watanabe SI; Yoshida T; Asamura H; Kanai Y; Arai E
Carcinogenesis; 2021 Feb; 42(2):169-179. PubMed ID: 33152763
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation profiles at precancerous stages associated with recurrence of lung adenocarcinoma.
Sato T; Arai E; Kohno T; Tsuta K; Watanabe S; Soejima K; Betsuyaku T; Kanai Y
PLoS One; 2013; 8(3):e59444. PubMed ID: 23544068
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome.
Yamanoi K; Arai E; Tian Y; Takahashi Y; Miyata S; Sasaki H; Chiwaki F; Ichikawa H; Sakamoto H; Kushima R; Katai H; Yoshida T; Sakamoto M; Kanai Y
Carcinogenesis; 2015 May; 36(5):509-20. PubMed ID: 25740824
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of a Methylome-based Malignancy Density Scoring System to predict recurrence risk in early-stage Lung Adenocarcinoma.
Yang L; Zhang J; Yang G; Xu H; Lin J; Shao L; Li J; Guo C; Du Y; Guo L; Li X; Han-Zhang H; Wang C; Chuai S; Ye J; Kang Q; Liu H; Ying J; Wang Y
Theranostics; 2020; 10(17):7635-7644. PubMed ID: 32685009
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of HSDL2 inhibits lung adenocarcinoma progression via down-regulating AKT2 expression.
Shi Y; Mao Z; Huang Y; Sun Y; Cao Q; Yin X; Huang J; Zhang Q
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32211805
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
[TBL] [Abstract][Full Text] [Related]
7. Cancer-testis gene PIWIL1 promotes cell proliferation, migration, and invasion in lung adenocarcinoma.
Xie K; Zhang K; Kong J; Wang C; Gu Y; Liang C; Jiang T; Qin N; Liu J; Guo X; Huo R; Liu M; Ma H; Dai J; Hu Z
Cancer Med; 2018 Jan; 7(1):157-166. PubMed ID: 29168346
[TBL] [Abstract][Full Text] [Related]
8. Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas.
Hu X; Estecio MR; Chen R; Reuben A; Wang L; Fujimoto J; Carrot-Zhang J; McGranahan N; Ying L; Fukuoka J; Chow CW; Pham HHN; Godoy MCB; Carter BW; Behrens C; Zhang J; Antonoff MB; Sepesi B; Lu Y; Pass HI; Kadara H; Scheet P; Vaporciyan AA; Heymach JV; Wistuba II; Lee JJ; Futreal PA; Su D; Issa JJ; Zhang J
Nat Commun; 2021 Jan; 12(1):687. PubMed ID: 33514726
[TBL] [Abstract][Full Text] [Related]
9. Relevance and prognostic ability of Twist, Slug and tumor spread through air spaces in lung adenocarcinoma.
Liu A; Sun X; Xu J; Xuan Y; Zhao Y; Qiu T; Hou F; Qin Y; Wang Y; Lu T; Wo Y; Li Y; Xing X; Jiao W
Cancer Med; 2020 Mar; 9(6):1986-1998. PubMed ID: 31970942
[TBL] [Abstract][Full Text] [Related]
10. Inactivating mutations and hypermethylation of the NKX2-1/TTF-1 gene in non-terminal respiratory unit-type lung adenocarcinomas.
Matsubara D; Soda M; Yoshimoto T; Amano Y; Sakuma Y; Yamato A; Ueno T; Kojima S; Shibano T; Hosono Y; Kawazu M; Yamashita Y; Endo S; Hagiwara K; Fukayama M; Takahashi T; Mano H; Niki T
Cancer Sci; 2017 Sep; 108(9):1888-1896. PubMed ID: 28677170
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: Its correlation with smoking history and chronic obstructive pulmonary disease.
Sato T; Arai E; Kohno T; Takahashi Y; Miyata S; Tsuta K; Watanabe S; Soejima K; Betsuyaku T; Kanai Y
Int J Cancer; 2014 Jul; 135(2):319-34. PubMed ID: 24921089
[TBL] [Abstract][Full Text] [Related]
12. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern Switzerland.
Grosse A; Grosse C; Rechsteiner M; Soltermann A
Diagn Pathol; 2019 Feb; 14(1):18. PubMed ID: 30744664
[TBL] [Abstract][Full Text] [Related]
14. Cooperative participation of epigenomic and genomic alterations in the clinicopathological diversity of gastric adenocarcinomas: significance of cell adhesion and epithelial-mesenchymal transition-related signaling pathways.
Yang M; Arai E; Takahashi Y; Totsuka H; Chiku S; Taniguchi H; Katai H; Sakamoto H; Yoshida T; Kanai Y
Carcinogenesis; 2020 Nov; 41(11):1473-1484. PubMed ID: 32710740
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Teashirt Homolog 2 suppresses cell proliferation and predicts the favorable survival of Lung Adenocarcinoma.
Zhao S; Guo X; Mizutani KI; Yamaguchi R; Yamada S; Gu C; Uramoto H
Int J Med Sci; 2021; 18(9):1980-1989. PubMed ID: 33850468
[No Abstract] [Full Text] [Related]
16. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
[No Abstract] [Full Text] [Related]
17. Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome.
Karlsson A; Jönsson M; Lauss M; Brunnström H; Jönsson P; Borg Å; Jönsson G; Ringnér M; Planck M; Staaf J
Clin Cancer Res; 2014 Dec; 20(23):6127-40. PubMed ID: 25278450
[TBL] [Abstract][Full Text] [Related]
18. Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma.
Chen YC; Lin MC; Hsiao CC; Zheng YX; Chen KD; Sung MT; Chen CJ; Wang TY; Lin YY; Chang HC; Chen YM; Chang JC
Oncotarget; 2017 Jul; 8(28):45710-45724. PubMed ID: 28498804
[TBL] [Abstract][Full Text] [Related]
19. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.
Selamat SA; Chung BS; Girard L; Zhang W; Zhang Y; Campan M; Siegmund KD; Koss MN; Hagen JA; Lam WL; Lam S; Gazdar AF; Laird-Offringa IA
Genome Res; 2012 Jul; 22(7):1197-211. PubMed ID: 22613842
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of clinicopathologic features and driver gene mutation in non-small cell lung cancer].
Chen LF; Chen XY; Yu XB
Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):221-5. PubMed ID: 27033383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
